ezogabine has been researched along with Depression, Involutional in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bagiella, E; Bevilacqua, L; Chadha, N; Collins, KA; Corniquel, M; Costi, S; Han, MH; Hoch, M; Iosifescu, DV; Iqbal, T; Jha, MK; Kirkwood, KA; Mathew, SJ; Morris, LS; Murrough, JW; Parides, MK; Pizzagalli, DA; Salas, R; Stern, ER; Swann, AC; Ursu, S; Vo-Le, B; Whitton, A | 1 |
| Ahle, G; Chadha, N; Collins, KA; Costi, S; Do, B; Friedman, AK; Han, MH; Iosifescu, DV; Kautz, M; Morris, LS; Murrough, JW; Nestler, EJ; Pizzagalli, DA; Tan, A; Van Dam, NT; Whitton, AE | 1 |
| Calizo, RC; Chaudhury, D; Dietz, DM; Friedman, AK; Han, MH; Hawkins, A; Juarez, B; Ku, SM; Murrough, JW; Neve, RL; Ribadeneira, M; Walsh, JJ; Wong, EH; Zhang, H; Zhang, S | 1 |
2 trial(s) available for ezogabine and Depression, Involutional
| Article | Year |
|---|---|
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
Topics: Adult; Anhedonia; Carbamates; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Functional Neuroimaging; Humans; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Magnetic Resonance Imaging; Male; Membrane Transport Modulators; Middle Aged; Phenylenediamines; Reward; Ventral Striatum | 2021 |
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder.
Topics: Carbamates; Depressive Disorder, Major; Female; Humans; Ion Channel Gating; KCNQ Potassium Channels; Magnetic Resonance Imaging; Male; Middle Aged; Phenylenediamines; Reward; Ventral Striatum | 2020 |
1 other study(ies) available for ezogabine and Depression, Involutional
| Article | Year |
|---|---|
KCNQ channel openers reverse depressive symptoms via an active resilience mechanism.
Topics: Adaptation, Psychological; Animals; Antidepressive Agents; Behavior, Animal; Carbamates; Depressive Disorder, Major; Disease Models, Animal; Dopaminergic Neurons; Electrophysiological Phenomena; Humans; KCNQ3 Potassium Channel; Male; Membrane Transport Modulators; Mice; Mice, Inbred C57BL; Phenylenediamines; Resilience, Psychological; Stress, Psychological; Ventral Tegmental Area | 2016 |